<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Dianthus Therapeutics Stock Earns RS Rating Upgrade — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Dianthus Therapeutics Stock Earns RS Rating Upgrade</h2>
    <div class="badge">2025-09-08T18:45:20+00:00</div>
    <ul>
      <li>IBD&#x27;s unique rating identifies share price movement with a 1 (worst) to 99 (best) score.</li>
<li>On Monday, Dianthus Therapeutics stock hit an important technical milestone, with its Relative Strength (RS) Rating climbing into the 80-plus percentile with an upgrade to 81, an increase from 74 the day before.</li>
<li>Is Dianthus Therapeutics Stock A Buy?</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Dianthus Therapeutics Stock Earns RS Rating Upgrade\n• IBD&#x27;s unique rating identifies share price movement with a 1 (worst) to 99 (best) score.\n• On Monday, Dianthus Therapeutics stock hit an important technical milestone, with its Relative Strength (RS) Rating climbing into the 80-plus percentile with an upgrade to 81, an increase from 74 the day before.\n• Is Dianthus Therapeutics Stock A Buy?" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/m/f2e22761-349e-3b0b-82bf-d9201c37cda0/dianthus-therapeutics-stock.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>